190 related articles for article (PubMed ID: 17954172)
1. Comparison of three methods for cyclosporine therapeutic monitoring.
Jebabli N; Klouz A; Bahlous A; Gaïes E; Trabelsi S; Lakhal M; Belkahia C
Transplant Proc; 2007 Oct; 39(8):2557-9. PubMed ID: 17954172
[TBL] [Abstract][Full Text] [Related]
2. [Problems associated with the use and monitoring of cyclosporin. Experience at a Clinical Pharmacology Service].
Loffreda A; Contaldi C; Santis DD; Marabese I; Chiaiese C; Formato P; Motola G; Russo F; D'Alessio O; Lampa E; Rossi F
Minerva Med; 1997 Dec; 88(12):543-9. PubMed ID: 9540786
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different cyclosporine immunoassays to monitor C0 and C2 blood levels from kidney transplant recipients: not simply overestimation.
Cattaneo D; Zenoni S; Murgia S; Merlini S; Baldelli S; Perico N; Gotti E; Ottomano C; Crippa A; Remuzzi G
Clin Chim Acta; 2005 May; 355(1-2):153-64. PubMed ID: 15820490
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of C0 and C2 blood concentrations of cyclosporine on the Roche Hitachi 902 analyzer.
Yargui L; Berhoune A
Transplant Proc; 2009 Nov; 41(9):3713-9. PubMed ID: 19917373
[TBL] [Abstract][Full Text] [Related]
5. Heparinized blood provides equivalent results to EDTA in the CEDIA and FPIA cyclosporine immunoassays, thus facilitating routine cyclosporine determination.
Korte WC; Engler H; Aldebert E; Riesen WF
Clin Chim Acta; 2008 Apr; 390(1-2):138-40. PubMed ID: 18230354
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine metabolism in patients after kidney, bone marrow, heart-lung, and liver transplantation in the early and late posttransplant periods.
Hamwi A; Salomon A; Steinbrugger R; Fritzer-Szekeres M; Jäger W; Szekeres T
Am J Clin Pathol; 2000 Oct; 114(4):536-43. PubMed ID: 11026099
[TBL] [Abstract][Full Text] [Related]
7. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
Ventura E; Bonardet A; Pageaux GP; Mourad G; Cristol JP
Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring on COBAS INTEGRA 400--evaluation results.
Domke I; Cremer P; Huchtemann M
Clin Lab; 2000; 46(9-10):509-15. PubMed ID: 11034537
[TBL] [Abstract][Full Text] [Related]
9. [Immunoanalytical methods of cyclosporine A determination].
Safarcík K; Komzáková I; Bartos V; Grundmann M
Ceska Slov Farm; 2002 May; 51(3):112-20. PubMed ID: 12058351
[TBL] [Abstract][Full Text] [Related]
10. High-performance liquid chromatography versus immunoassay for the measurement of sirolimus: comparison of two methods.
Zochowska D; Bartłomiejczyk I; Kamińska A; Senatorski G; Paczek L
Transplant Proc; 2006; 38(1):78-80. PubMed ID: 16504669
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of everolimus and cyclosporine concentrations by HPLC with ultraviolet detection.
Baldelli S; Zenoni S; Merlini S; Perico N; Cattaneo D
Clin Chim Acta; 2006 Feb; 364(1-2):354-8. PubMed ID: 16153624
[TBL] [Abstract][Full Text] [Related]
12. The V-twin system (Dade Behring Laboratories): a useful tool for immunosuppressive drug monitoring.
Elaerts S; Olejnik Y; Bonardet A; Garrigue V; Mourad G; Cristol JP; Dupuy AM
Transplant Proc; 2005; 37(1):167-71. PubMed ID: 15808583
[TBL] [Abstract][Full Text] [Related]
13. [Determination of cyclosporine A using high-performance liquid chromatography].
Komzáková I; Brozmanová H; Safarcík K; Grundmann M
Ceska Slov Farm; 2002 May; 51(3):107-11. PubMed ID: 12058350
[TBL] [Abstract][Full Text] [Related]
14. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
Koster RA; Dijkers EC; Uges DR
Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporin A pharmacokinetics and efficacy in the treatment of atopic dermatitis in dogs.
Steffan J; Strehlau G; Maurer M; Rohlfs A
J Vet Pharmacol Ther; 2004 Aug; 27(4):231-8. PubMed ID: 15305852
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of four automated methods for determination of whole blood cyclosporine concentrations.
Hamwi A; Veitl M; Männer G; Ruzicka K; Schweiger C; Szekeres T
Am J Clin Pathol; 1999 Sep; 112(3):358-65. PubMed ID: 10478141
[TBL] [Abstract][Full Text] [Related]
17. Determination of cyclosporine and its metabolites in blood via HPLC-MS and correlation to clinically important parameters.
Vollenbroeker B; Koch JH; Fobker M; Suwelack B; Hohage H; Müller U
Transplant Proc; 2005 May; 37(4):1741-4. PubMed ID: 15919451
[TBL] [Abstract][Full Text] [Related]
18. Comparison of fluorescent polarization immunoassay (FPIA) versus HPLC to measure everolimus blood concentrations in clinical transplantation.
Khoschsorur G; Fruehwirth F; Zelzer S; Stettin M; Halwachs-Baumann G
Clin Chim Acta; 2007 May; 380(1-2):217-21. PubMed ID: 17320846
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC.
Schütz E; Svinarov D; Shipkova M; Niedmann PD; Armstrong VW; Wieland E; Oellerich M
Clin Chem; 1998 Oct; 44(10):2158-64. PubMed ID: 9761250
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of cyclosporine and tacrolimus in human whole blood by ultra-high performance liquid chromatography tandem mass spectrometry and comparison with a chemiluminescence microparticle immunoassay.
Mei S; Wang J; Chen D; Zhu L; Zhao M; Tian X; Hu X; Zhao Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1087-1088():36-42. PubMed ID: 29704799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
